MRI上髌上脂肪垫高信号改变与48个月后髌股关节退变相关:来自骨关节炎倡议的数据
基于骨关节炎倡议426例无放射学胫股骨关节炎受试者,基线3T MRI评估髌上脂肪垫高信号和占位效应,随访48个月。基线51%存在髌上脂肪垫信号改变,其髌骨和滑车软骨病变进展及骨髓病变进展风险均显著高于无信号改变者;占位效应与关节退变无关,髌上脂肪垫表现与临床症状恶化无关。
要点
- 基线髌上脂肪垫高信号见于51%受试者,其中11%伴占位效应。
- 有髌上脂肪垫信号改变者48个月髌骨和滑车软骨病变进展显著高于无信号改变者。
- 髌上脂肪垫信号改变者骨髓病变进展风险升高(OR 1.75)。
核心结论
- 48个月随访中,髌上脂肪垫信号改变者髌股关节退变显著增加,提示髌上脂肪垫异常与髌股骨关节炎进展相关。
研究设计与样本
- 骨关节炎倡议(OAI)队列研究,纳入426例无放射学胫股骨关节炎受试者(51.8±3.8岁,49.8%女性),基线及48个月行右膝3T MRI和膝关节损伤与骨关节炎结局评分临床评估。
关键影像表现/征象
- 髌上脂肪垫高信号在中间加权脂肪饱和快速自旋回波序列上评估。
- 占位效应定义为髌上脂肪垫后缘呈凸面轮廓。
诊断标准与关键数值
- 髌骨软骨病变进展调整后平均增加量:有信号改变组0.29(95%CI -0.07至0.64) vs 无信号改变组-0.04(95%CI -0.40至0.31),p<0.001。
- 滑车软骨病变进展调整后平均增加量:有信号改变组0.47(95%CI 0.16至0.77) vs 无信号改变组0.31(95%CI 0.01至0.61),p=0.007。
- 骨髓病变进展:有信号改变组 vs 无信号改变组 OR 1.75(95%CI 1.09至2.82),p=0.021。
临床应用与阅片要点
- 髌上脂肪垫高信号改变可能提示髌股关节退变进展风险较高。
- 占位效应与关节退变无关。
- 髌上脂肪垫表现与临床症状恶化无关(所有p>0.18)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To analyze associations of suprapatellar fat pad (SPFP) hyperintense signal alterations and mass effect with progression of patellofemoral osteoarthritis (OA) and clinical symptoms over 48 months.
MATERIALS AND METHODS: Subjects from the Osteoarthritis Initiative (n = 426; 51.8 ± 3.8 years; 49.8% women) without radiographic tibiofemoral OA underwent 3T-MRI of their right knees and clinical evaluation using the Knee Injury and Osteoarthritis Outcome Score at baseline and at 48 months. Elevated SPFP signal was assessed on intermediate-weighted, fat-saturated turbo spin-echo (TSE) images. Mass effect was defined as a convex posterior contour. Patellofemoral cartilage, bone marrow lesions (BML), and subchondral cysts were assessed using the Whole-Organ Magnetic Resonance Imaging Score (WORMS). Associations of SPFP imaging findings with MRI and clinical progression were assessed using general linear models and logistic regressions.
RESULTS: Baseline SPFP signal alterations were found in 51% of the subjects (n = 217), of whom 11% (n = 23) additionally had a mass effect. Progression of cartilage lesions was significantly higher in subjects with signal alteration versus without (adjusted mean increases, 95% CI; patella: 0.29, -0.07 to 0.64 vs -0.04, -0.40 to 0.31; p < 0.001; trochlea: 0.47, 0.16 to 0.77 vs 0.31, 0.01 to 0.61; p = 0.007). BML progression was also more likely in subjects with signal alteration (OR 1.75, 95% CI 1.09 to 2.82; p = 0.021). Mass effect was not associated with joint degeneration and SPFP findings were not associated with clinical worsening (p > 0.18 for all).
CONCLUSION: Patellofemoral joint degeneration over 48 months was significantly increased in subjects with SPFP signal alteration, suggesting an association between SPFP abnormalities and the progression of patellofemoral OA.
引用
- Schwaiger BJ, Mbapte Wamba J, Gersing AS, et al. Hyperintense signal alteration in the suprapatellar fat pad on MRI is associated with degeneration of the patellofemoral joint over 48 months: data from the Osteoarthritis Initiative. Skeletal Radiol. 2017. PMID: 28944439. doi:10.1007/s00256-017-2771-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。